Global Insulin Delivery Devices Market Outlook 2018
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2014| No. of Pages : 120
List of Figures:
Figure 3-1: Global - Number of Diabetic Patients (Million), 2013 & 2030
Figure 3-2: Global - Insulin Market (Billion US$), 2013-2018
Figure 3-3: Global - Insulin Market by Type of Packaging (%), 2013
Figure 3-4: Global - Insulin Market by Region (%), 2013
Figure 3-5: Global - Insulin Market by Player (%), 2013
Figure 6-1: Global - Insulin Delivery Devices Market (Billion US$), 2013-2018
Figure 6-2: Global - Insulin Delivery Devices Market by Segment (%), 2013
Figure 6-3: US - Insulin Delivery Devices Market (Billion US$), 2013-2018
Figure 6-4: US - Insulin Delivery Devices Market by Segment (%), 2013
Figure 6-5: US - Insulin Delivery Devices Market by Segment (%), 2018
Figure 6-6: US - Insulin Pen Market (Billion US$), 2013-2018
Figure 6-7: US - Insulin Syringe Market (Million US$), 2013-2018
Figure 6-8: US - Insulin Pump Market (Million US$), 2013-2018
Figure 6-9: US - Insulin Jet Injector Market (Million US$), 2013-2018
Figure 6-10: Japan - Insulin Delivery Devices Market (Billion US$), 2013-2018
Figure 6-11: Japan - Insulin Pen Market (Million US$), 2013-2018
Figure 6-12: Japan - Insulin Syringe Market (Million US$), 2013-2018
Figure 6-13: China - Insulin Delivery Devices Market (Million US$), 2013-2018
Figure 6-14: China - Insulin Pen Market (Million US$), 2013-2018
Figure 6-15: China - Insulin Syringe Market (Million US$), 2013-2018
Figure 6-16: Brazil - Insulin Delivery Devices Market (Million US$), 2013-2018
Figure 6-17: Brazil - Insulin Pen Market (Million US$), 2013-2018
Figure 6-18: Brazil - Insulin Syringe Market (Million US$), 2013-2018
Figure 6-19: India - Insulin Delivery Devices Market (Million US$), 2013-2018
Figure 6-20: India - Insulin Pen Market (Million US$), 2013-2018
Figure 6-21: India - Insulin Syringe Market (Million US$), 2013-2018
Figure 7-1: Global - Insulin Pen Market (Billion US$), 2013-2018
Figure 7-2: Global - Insulin Pen Market by Region (%), 2013
Figure 7-3: Global - Insulin Pen Market by Region (%), 2018
Figure 7-4: Global - Insulin Pump Market (Million US$), 2013-2018
Figure 7-5: Global - Share of Medtronic in Insulin Pumps Market (2010)
Figure 7-6: Global - Insulin Syringes Market (Million US$), 2013-2018
Figure 7-7: Global - Insulin Syringes Market by Region (%), 2013
Figure 7-8: Global - Insulin Syringes Market by Region (%), 2018
Figure 7-9: Global - Insulin Jet Injectors Market (Million US$), 2013-2018
Figure 9-1: Novo Nordisk - Share of Diabetic Products of by Value (2013)
Figure 9-2: Novo Nordisk - Sales by Geographic Regions (%), 2013
Figure 9-3: Eli Lilly - Sales by Business Segments (%), 2013
Figure 9-4: Eli Lilly - Sales by Geographic Regions (%), 2013
Figure 9-5: Medtronic - Sales by Business Segments (%), 2013
Figure 9-6: Medtronic - Sales by Geographic Regions (%), 2013
Figure 9-7: BD Global - Sales by Business Segments (%), 2013
Figure 9-8: BD Medical - Sales by Business Segments (%), 2013
Figure 9-9: BD Global - Sales by Geographic Regions (%), 2013
Figure 9-10: Sanofi-Aventis - Sales by Geographic Regions (%), 2013
Figure 9-11: Roche - Sales by Business Segments (%), 2013
Figure 9-12: Roche - Sales of In-Vitro Diagnostics by Segments (%), 2013
Figure 9-13: Roche - Sales by Geographic Regions (%), 2013
Figure 9-14: Ypsomed - Sales by Geographic Regions (%), 2013
Figure 9-15: J&J - Sales by Business Segments (%), 2013
Figure 9-16: B.Braun - Sales by Geographic Regions (%), 2013
Figure 9-17: Abbott - Sales by Business Segments (%), 2013
Figure 9-18: Abbott - Sales of Medical Devices by Segments (%), 2013
Figure 9-19: Abbott - Sales by Geographic Regions (%), 2013
List of Tables:
Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2013 & 2030
Table 4-1: Commercially available Insulin Pumps
Table 5-1: Risk factors associated with Insulin Pumps
Table 5-2: Risk factors associated with Insulin Pen
Table 6-1: US - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Table 6-2: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Table 6-3: China - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Table 6-4: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Table 6-5: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2030
Table 7-1: Global - Key Insulin Pen Products by Company
Table 7-2: Global - Key Insulin Syringes Products by Company
Table 9-1: Novo Nordisk - Sales by Business Segments (Million US$), 2011-2013
Table 9-2: Novo Nordisk - Diabetes Product Sales by Geographic Regions (Million US$), 2011-2013
Table 9-3: Eli Lilly - Sales by Business Segments (Million US$), 2011-2013
Table 9-4: Eli Lilly - Sales by Geographic Regions (Million US$), 2011-2013
Table 9-5: Medtronic - Sales by Business Segments (Million US$), 2011-2013
Table 9-6: BD Global - Sales by Business Segments (Million US$), 2011-2013
Table 9-7: BD Medical - Sales by Business Segments (Million US$), 2011-2013
Table 9-8: Sanofi-Aventis - Sales by Business Segments (Million US$), 2011-2013
Table 9-9: Insulet Corporation - Sales of Insulin Pumps (Million US$), 2011-2013
Table 9-10: J&J - Sales by Business Segments (Million US$), 2011-2013
Table 9-11: J&J - Sales of Medical Devices & Diagnostics by Segments (Million US$), 2011-2013